The intracellular signaling pathway involving the PI3K/Akt/mTOR/S6 plays an important role in cell proliferation in PAH and it is thought to be a promising therapeutic target for this syndrome [41], [42], [43]. This evidence concerns the gene AKT1 and pulmonary arterial hypertension.